Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.
2.

Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis.

Mialdea M, Sangle SR, D'Cruz DP.

J Autoimmune Dis. 2009 May 19;6:3. doi: 10.1186/1740-2557-6-3.

3.

Prevalence of antibodies to Ro-52 in a serologically defined population of patients with systemic sclerosis.

Parker JC, Burlingame RW, Bunn CC.

J Autoimmune Dis. 2009 Mar 6;6:2. doi: 10.1186/1740-2557-6-2.

4.

Are classification criteria for vasculitis useful in clinical practice? Observations and lessons from Colombia.

Patarroyo PA, Restrepo JF, Rojas SA, Rondón F, Matteson EL, Iglesias-Gamarra A.

J Autoimmune Dis. 2009 Feb 27;6:1. doi: 10.1186/1740-2557-6-1.

5.

Controversies in the antiphospholipid syndrome: can we ever stop warfarin?

Fonseca AG, D'Cruz DP.

J Autoimmune Dis. 2008 Nov 11;5:6. doi: 10.1186/1740-2557-5-6.

6.

Retraction: analysis of the TCR alpha and beta chain CDR3 spectratypes in the peripheral blood of patients with Systemic Lupus Erythematosus.

Luo W, Ma L, Wen Q, Yao XS, Wang N, Zou HY, Zhou MQ, Lin Y, Wu ZQ, He XW, Wang JF, Wang XN.

J Autoimmune Dis. 2008 Aug 11;5:5. doi: 10.1186/1740-2557-5-5. No abstract available.

7.

Analysis of the TCR alpha and beta chain CDR3 spectratypes in the peripheral blood of patients with Systemic Lupus Erythematosus.

Luo W, Ma L, Wen Q, Yao XS, Wang N, Zou HY, Zhou MQ, Lin Y, Wu ZQ, He XW, Wang JF, Wang XN.

J Autoimmune Dis. 2008 Jul 29;5:4. doi: 10.1186/1740-2557-5-4. No abstract available. Retraction in: Luo W, Ma L, Wen Q, Yao XS, Wang N, Zou HY, Zhou MQ, Lin Y, Wu ZQ, He XW, Wang JF, Wang XN. J Autoimmune Dis. 2008;5:5.

8.

Autoantigenic nuclear proteins of a clinically atypical renal vasculitis.

Avila J, Acosta E, Machargo MD, Arteaga MF, Gallego E, Cañete H, García-Pérez JJ, Martín-Vasallo P.

J Autoimmune Dis. 2008 Jul 14;5:3. doi: 10.1186/1740-2557-5-3.

9.

Association of Epstein-Barr virus antibody titers with a human IL-10 promoter polymorphism in Japanese women.

Yasui Y, Hamajima N, Nakamura T, El-Din NS, Tajima K, Potter JD.

J Autoimmune Dis. 2008 Mar 4;5:2. doi: 10.1186/1740-2557-5-2.

10.

Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases.

Fridkis-Hareli M.

J Autoimmune Dis. 2008 Feb 15;5:1. doi: 10.1186/1740-2557-5-1.

11.
12.

The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders.

Papamichalis PA, Zachou K, Koukoulis GK, Veloni A, Karacosta EG, Kypri L, Mamaloudis I, Gabeta S, Rigopoulou EI, Lohse AW, Dalekos GN.

J Autoimmune Dis. 2007 Jun 29;4:3.

13.

Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis.

Rigopoulou EI, Mytilinaiou M, Romanidou O, Liaskos C, Dalekos GN.

J Autoimmune Dis. 2007 Feb 4;4:2.

14.

Autoantibodies against the chromosomal passenger protein INCENP found in a patient with Graham Little-Piccardi-Lassueur syndrome.

Rodríguez-Bayona B, Ruchaud S, Rodríguez C, Linares M, Astola A, Ortiz M, Earnshaw WC, Valdivia MM.

J Autoimmune Dis. 2007 Jan 12;4:1. doi: 10.1186/1740-2557-4-1.

15.

Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.

Cordiali-Fei P, Trento E, D'Agosto G, Bordignon V, Mussi A, Ardigò M, Mastroianni A, Vento A, Solivetti F, Berardesca E, Ensoli F.

J Autoimmune Dis. 2006 Oct 5;3:5.

16.

Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study.

Slot MC, Theunissen R, van Paassen P, Damoiseaux JG, Tervaert JW.

J Autoimmune Dis. 2006 May 5;3:4.

17.

Cerebrovascular disease associated with antiphospholipid antibodies: more questions than answers.

Hawkins C, Gatenby P, Tuck R, Danta G, Andrews C.

J Autoimmune Dis. 2006 Mar 30;3:3.

18.

Endothelial cell activation and neovascularization are prominent in dermatomyositis.

Nagaraju K, Rider LG, Fan C, Chen YW, Mitsak M, Rawat R, Patterson K, Grundtman C, Miller FW, Plotz PH, Hoffman E, Lundberg IE.

J Autoimmune Dis. 2006 Feb 20;3:2.

19.

Virus-mediated autoimmunity in Multiple Sclerosis.

Grigoriadis N, Hadjigeorgiou GM.

J Autoimmune Dis. 2006 Feb 19;3:1.

20.

Phenytoin as a novel anti-vitiligo weapon.

Namazi MR.

J Autoimmune Dis. 2005 Nov 22;2:11.

Supplemental Content

Loading ...
Support Center